Abstract.
1 Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/
INTRODUCTION
cant levels of impairment in other cognitive domains, aimed to achieve a balance of normal controls, MCI, 168 and AD subjects. For ADNI 1, a random subsample 169 of subjects was selected for FDG imaging; in ADNI 170 2/GO, all subjects enrolled received FDG imaging.
171
For up-to-date information on specific inclusion and 172 exclusion criteria, please see http://www.adni-info.org.
173
Psychometric testing 174 We aimed to include a battery of psychometric tests 175 that would cover a broad range of cognitive domains, 176 with special focus on memory due to its importance in 177 AD. For memory, we included components of the Rey 178 Auditory Verbal Learning Test (AVLT) [17] given its Making Test [18] (Trails A and Trails B) was used; for 184 language/semantics, category fluency [19] (Animals) 185 and the Boston Naming Test [20] were examined; and 186 as a measure of global cognition, the MMMSE was 187 utilized [21] . We examined several of the AVLT mea-188 sures, which depend on differential aspects of episodic 189 and working memory [22] . The AVLT consists of five [28, 29] . The SVD was performed using the princomp 273 function in R, and we retained the top 10 components.
274
A grid search strategy using bootstrapping with 100 275 repetitions, with half the subjects left out for a valida-276 tion cohort, was used to determine the optimal number 277 of components to retain.
Statistical analysis

278
All statistical analysis was performed using the R 279 programming language, version 3.1.0. For predictive 280 studies, we randomly split the subjects 5 times into 281 training and testing cohorts, retaining half the subjects 282 for training and using the other half for testing in a 283 5 × 2 cross-validation scheme [30] ing information, is given in Table 1 . We computed 
300
RESULTS
301
Subject demographics
682
Neurobiol Aging 32, 2322.e19-2322.e27.
683
[4] Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor
